Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated:  12/21/2017
Primary Children's Hospital
699
mi
from 98109
Salt Lake City, UT
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated: 12/21/2017
Primary Children's Hospital
699
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated:  12/21/2017
Sick Children's Hospital
2065
mi
from 98109
Toronto,
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus
Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study
Status: Enrolling
Updated: 12/21/2017
Sick Children's Hospital
2065
mi
from 98109
Toronto,
Click here to add this to my saved trials
Comparison of Culture Media for in Vitro Embryo Development
Prospective Observational Study Utilizing Next Generation Continuous Single Culture Media (CSCM2) for Comparative in Vitro Embryo Development and Outcome Data
Status: Enrolling
Updated:  12/22/2017
Ovation Fertility - Austin
1770
mi
from 98109
Austin, TX
Comparison of Culture Media for in Vitro Embryo Development
Prospective Observational Study Utilizing Next Generation Continuous Single Culture Media (CSCM2) for Comparative in Vitro Embryo Development and Outcome Data
Status: Enrolling
Updated: 12/22/2017
Ovation Fertility - Austin
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator
Prospective Observational and Validation Study Using Time-lapse Morphometry MIRI Imaging Incubator (TiMMI Study)
Status: Enrolling
Updated:  12/22/2017
Ovation Fertility
1766
mi
from 98109
Austin, TX
Validation Study Using a Time-lapse Morphometry MIRI Imaging Incubator
Prospective Observational and Validation Study Using Time-lapse Morphometry MIRI Imaging Incubator (TiMMI Study)
Status: Enrolling
Updated: 12/22/2017
Ovation Fertility
1766
mi
from 98109
Austin, TX
Click here to add this to my saved trials
Impact of Hot Flashes on Sleep and Mood Disturbance
Impact of Experimentally Induced Hot Flashes on Sleep and Mood Disturbance
Status: Enrolling
Updated:  12/26/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Impact of Hot Flashes on Sleep and Mood Disturbance
Impact of Experimentally Induced Hot Flashes on Sleep and Mood Disturbance
Status: Enrolling
Updated: 12/26/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Alabama at Birmingham
2072
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Northwestern University
1733
mi
from 98109
Chicago, IL
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Northwestern University
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Wayne State University
1931
mi
from 98109
Detroit, MI
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Wayne State University
1931
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Columbia University
2400
mi
from 98109
New York, NY
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Columbia University
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of North Carolina at Chapel Hill
2329
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Wake Forest University School of Medicine
2275
mi
from 98109
Winston-Salem, NC
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Wake Forest University School of Medicine
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Case Western University
2024
mi
from 98109
Cleveland, OH
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Case Western University
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Dexel University
2372
mi
from 98109
Philadelphia, PA
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Dexel University
2372
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Pittsburgh-Magee Womens Hospital
2134
mi
from 98109
Pittsburgh, PA
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Pittsburgh-Magee Womens Hospital
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
Brown University
2486
mi
from 98109
Providence, RI
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
Brown University
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Texas - Southwest
1676
mi
from 98109
Dallas, TX
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Texas - Southwest
1676
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
The University of Texas, Houston
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated:  12/26/2017
University of Utah Medical Center
702
mi
from 98109
Salt Lake City, UT
Fetal Pulse Oximetry Trial (FOX)
A Randomized Clinical Trial of Fetal Pulse Oximetry
Status: Enrolling
Updated: 12/26/2017
University of Utah Medical Center
702
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
A Phase II Trial of Bevacizumab (rhuMAB VEGF) (NSC #704865) in the Treatment of Persistent and Recurrent Squamous Cell Carcinoma of the Cervix (Group A)
Status: Enrolling
Updated:  12/27/2017
Gynecologic Oncology Group
2373
mi
from 98109
Philadelphia, PA
Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
A Phase II Trial of Bevacizumab (rhuMAB VEGF) (NSC #704865) in the Treatment of Persistent and Recurrent Squamous Cell Carcinoma of the Cervix (Group A)
Status: Enrolling
Updated: 12/27/2017
Gynecologic Oncology Group
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Status: Enrolling
Updated:  12/30/2017
William Beaumont Hospital
1921
mi
from 98109
Royal Oak, MI
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Status: Enrolling
Updated: 12/30/2017
William Beaumont Hospital
1921
mi
from 98109
Royal Oak, MI
Click here to add this to my saved trials
Recombinant Human Prolactin for Lactation Induction
Recombinant Human Prolactin for Lactation Induction in Mothers of Premature Infants
Status: Enrolling
Updated:  12/31/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Recombinant Human Prolactin for Lactation Induction
Recombinant Human Prolactin for Lactation Induction in Mothers of Premature Infants
Status: Enrolling
Updated: 12/31/2017
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
Phase I Investigation of the Feasibility of Combining 5-azacytidine With Highdose Cytarabine (HiDAC) and Mitoxantrone Chemotherapy in a Sequential Manner for Remission Induction in High-risk Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  1/2/2018
University of Chicago Comprehensive Cancer Center
1733
mi
from 98109
Chicago, IL
Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia
Phase I Investigation of the Feasibility of Combining 5-azacytidine With Highdose Cytarabine (HiDAC) and Mitoxantrone Chemotherapy in a Sequential Manner for Remission Induction in High-risk Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 1/2/2018
University of Chicago Comprehensive Cancer Center
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated:  1/3/2018
University of Oklahoma Health Sciences Center
1524
mi
from 98109
Oklahoma City, OK
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated: 1/3/2018
University of Oklahoma Health Sciences Center
1524
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated:  1/3/2018
University of Oklahoma Children's Hospital
1524
mi
from 98109
Oklahoma City, OK
Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation
Administration of Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation Protocol: A Pilot Trial
Status: Enrolling
Updated: 1/3/2018
University of Oklahoma Children's Hospital
1524
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) - Phase 1 Clinical Trial
Status: Enrolling
Updated:  1/3/2018
Virginia Commonwealth University
2352
mi
from 98109
Richmond, VA
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention
Initial Efficacy Study of Supporting Play, Exploration, & Early Development Intervention (SPEEDI) - Phase 1 Clinical Trial
Status: Enrolling
Updated: 1/3/2018
Virginia Commonwealth University
2352
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated:  1/3/2018
Denver Health
1019
mi
from 98109
Denver, CO
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated: 1/3/2018
Denver Health
1019
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated:  1/3/2018
Washington University in St. Louis
1716
mi
from 98109
Saint Louis, MO
Diabetes Group Prenatal Care
Group Prenatal Care for Women With Diabetes: A Pilot Randomized Control Trial
Status: Enrolling
Updated: 1/3/2018
Washington University in St. Louis
1716
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2079
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2049
mi
from 98109
Cullman, AL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2049
mi
from 98109
Cullman, AL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2151
mi
from 98109
Mobile, AL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2151
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1128
mi
from 98109
Chandler, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1128
mi
from 98109
Chandler, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1103
mi
from 98109
Goodyear, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1103
mi
from 98109
Goodyear, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1220
mi
from 98109
Tucson, AZ
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1220
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1782
mi
from 98109
Little Rock, AR
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
976
mi
from 98109
Artesia, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
976
mi
from 98109
Artesia, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
625
mi
from 98109
Carmichael, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
625
mi
from 98109
Carmichael, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
971
mi
from 98109
Chino, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
971
mi
from 98109
Chino, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1041
mi
from 98109
Encinitas, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1041
mi
from 98109
Encinitas, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1070
mi
from 98109
Colorado Springs, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1070
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1020
mi
from 98109
Denver, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1020
mi
from 98109
Denver, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1018
mi
from 98109
Lakewood, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1018
mi
from 98109
Lakewood, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
1033
mi
from 98109
Lonetree, CO
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
1033
mi
from 98109
Lonetree, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2470
mi
from 98109
Groton, CT
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2470
mi
from 98109
Groton, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2468
mi
from 98109
New London, CT
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2468
mi
from 98109
New London, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2425
mi
from 98109
Southington, CT
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2425
mi
from 98109
Southington, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2701
mi
from 98109
Boynton Beach, FL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2701
mi
from 98109
Boynton Beach, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/3/2018
Clinical Research Facility
2512
mi
from 98109
Clearwater, FL
Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/3/2018
Clinical Research Facility
2512
mi
from 98109
Clearwater, FL
Click here to add this to my saved trials